Theoretically, understanding the HSP role in carcinogenesis may enable blocking of carcinogenesis checkpoints and contribute to cancer prevention in high-risk groups, comprised patients with hereditary syndromes or preneoplastic conditions, such as Barrett esophagus, atrophic gastritis, HPV or EBV viral infections [41,88,89,90]. This evidence concerns the gene HSP90B2P and cancer.